Key result
A unified and integrated approach to treating concomitant hypertension and dyslipidemia is recommended to effectively manage cardiovascular risk.
Concomitant hypertension and dyslipidemia increase cardiovascular risk and may benefit from an integrated treatment approach.
Answers are grounded in this paper and cite their sources.
May support integrated management of concomitant hypertension and dyslipidemia; leaves open need for randomized confirmation.
Hypertension and dyslipidemia often coexist, increasing the risk of cardiovascular disease. Evidence suggesting that concomitant hypertension and dyslipidemia are compelling candidates for a unified approach to treating cardiovascular risk is reviewed in this article. The authors also discuss important new findings documenting the need for, and benefits of, a more integrated approach to treating this dangerous duo.
No takes yet. Share an insight, caveat, or question.
David T. Nash (2006) conducted a review in Concomitant hypertension and dyslipidemia. Unified approach to treating cardiovascular risk was evaluated. A unified and integrated approach to treating concomitant hypertension and dyslipidemia is recommended to effectively manage cardiovascular risk.
Synapse has enriched 10 related papers. Consider them for comparative context: